CELU vs CGTX

Celularity Inc. vs Cognition Therapeutics, Inc. — Valuation Comparison 2026

CELU

Biotechnology
Celularity Inc.
Quality
4.9
out of 10
Value Trap
36
LOW
Price
$0.99
Last close
Models
7/13
Active
VS

CGTX

Biotechnology
Cognition Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
36
LOW
Price
$1.19
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType CELU Fair ValueCELU Upside CGTX Fair ValueCGTX Upside
Bayesian DCF Intrinsic $0.51 -57.3%
Earnings Power Value Intrinsic $3.41 +256.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.64 -45.8%
PWERM Option-Based $4.08 +311.8% $1.20 +0.6%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CELU vs CGTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CELU vs CGTX — Which Stock Is More Undervalued?

CELU scores higher with a 4.9/10 quality rating vs CGTX's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Celularity Inc. (CELU) and Cognition Therapeutics, Inc. (CGTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CELU currently trades at $0.99 with a QOC of 4.9/10, while CGTX trades at $1.19 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).